Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 6/20 | 0.36 |
| ▸ | CES2 | O00748 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 8/20 | 0.35 |
| ▸ | PAM | P19021 | 2/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphonic Acid SCHEMBL8154532 | 0.92 | ALDH1A1 (0.41) | ALDH1A1HTTDGKACES1CES2 | |
| SCHEMBL2691702 | 0.87 | DGKA (0.50) | ALDH1A1HTTDGKACES1CES2 | |
| SCHEMBL4951808 | 0.85 | HTT (0.54) | ALDH1A1HTTMEN1KMT2AHSD17B10 | |
| SCHEMBL2692664 | 0.85 | DGKA (0.59) | ALDH1A1DGKACES1CES2MEN1 | |
| SCHEMBL10172890 | 0.84 | CYP1A2 (0.47) | ALDH1A1HTTMEN1KMT2AHSD17B10 | |
| SCHEMBL24961269 | 0.84 | DGKA (0.62) | ALDH1A1DGKACES1CES2MEN1 | |
| SCHEMBL6509263 | 0.84 | DGKA (0.62) | ALDH1A1DGKACES1CES2MEN1 | |
| SCHEMBL835850 | 0.84 | DGKA (0.62) | ALDH1A1DGKACES1CES2MEN1 | |
| SCHEMBL21257703 | 0.84 | DGKA (0.62) | ALDH1A1DGKACES1CES2MEN1 | |
| SCHEMBL21257687 | 0.84 | DGKA (0.62) | ALDH1A1DGKACES1CES2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 624 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12638144-B2 | Covalent organic frameworks | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-26 | — | — | US | claimed |
| US-20260100414-A1 | FLAME-RETARDANT OR NON-FLAMMABLE POLYMER GEL ELECTROLYTE, LITHIUM BATTERY INCLUDING THE SAME, SUPRAMOLECULAR POLYMER, AND METHOD OF PREPARING THE SUPRAMOLECULAR POLYMER | THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC) (KR) | 2026-04-09 | — | — | US | claimed |
| US-12575775-B2 | Intra-body electrode with a poly(3,4-ethylenedioxythiophene)-based coating | MEDTRONIC, INC. (US) | 2026-03-17 | — | — | US | claimed |
| US-20260005313-A1 | ELECTROLYTE INCLUDING ELECTROLYTE SOLVENT, FLUOROETHER, AND BIS(FLUOROSULFONYL) SALT, AND LITHIUM METAL ELECTROCHEMICAL CELLS INCLUDING THE SAME | 24M TECHNOLOGIES, INC. (US) | 2026-01-01 | — | — | US | claimed |
| US-20250372719-A1 | CHEMICAL ADDITIVES FOR LIQUEFIED GAS ELECTROLYTES | SOUTH 8 TECH INC (US) | 2025-12-04 | — | — | US | claimed |
| US-20250357543-A1 | ELECTROLYTES INCLUDING FLUORINATED ORGANIC SOLVENT MIXTURES FOR BATTERIES INCLUDING HIGH-VOLTAGE POSITIVE ELECTRODE MATERIALS AND BATTERIES INCLUDING THE SAME | GM GLOBAL TECH OPERATIONS LLC (US) | 2025-11-20 | — | — | US | claimed |
| WO-2025233808-A1 | MULTICOMPONENT COFS AND METHODS OF MAKING AND USING SAME | NEW YORK UNIVERSITY IN ABU DHABI CORPORATION (AE) | 2025-11-13 | — | — | WO | claimed |
| US-20250329799-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY SAFETY | Anthro Energy, Inc. (US) | 2025-10-23 | — | — | US | claimed |
| US-20250309353-A1 | HIGH PERFORMANCE ELECTROLYTE FOR ELECTROCHEMICAL ENERGY STORAGE DEVICES, AND METHODS OF PRODUCING THE SAME | 24M TECHNOLOGIES, INC. | 2025-10-02 | — | — | US | claimed |
| WO-2025093455-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED ENERGY DENSITY | SPECIALTY OPERATIONS FRANCE (FR) | 2025-05-08 | — | — | WO | claimed |
| WO-2004058701-A2 | BIOCATALYTIC PREPARATION OF ENANTIOMERICALLY ENRICHED AMINOPENTANENITRILE | PCBU SERVICES, INC. (US) | 2004-07-15 | — | — | WO | claimed |
| US-20040121435-A1 | Biocatalytic preparation of enantiomerically enriched aminopentanenitrile | PFIZER INC. | 2004-06-24 | — | — | US | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| WO-2003083126-A2 | ENZYMATIC RESOLUTION OF PROPYLENE GLYCOL ALKYL (OR ARYL) ETHERS AND ETHER ACETATES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-10-09 | — | — | WO | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| EP-1002123-A1 | ENZYMATIC KINETIC RESOLUTION OF AN INTERMEDIATE USEFUL FOR PREPARING SUBSTITUTED TRICYCLICS | SCHERING CORPORATION (US) | 2000-05-24 | — | — | EP | claimed |
| US-6037166-A | MULTISTEP PROCESS USING HYDROLASE AND ACYLATING AGENT; OPTIONALLY CONVERTING UNDESIRED ISOMERS INTO RACEMATE BY HEATING AND RESUBJECTING TO PROCESS; FOR ANTIHISTAMINES AND INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | SCHERING CORPORATION (US) | 2000-03-14 | — | — | US | claimed |
| WO-1998058073-A1 | ENZYMATIC KINETIC RESOLUTION OF AN INTERMEDIATE USEFUL FOR PREPARING SUBSTITUTED TRICYCLICS | SCHERING CORPORATION (US) | 1998-12-23 | — | — | WO | claimed |
| US-H1679-H | Process for preparing an optically pure intermediate for a phosphonosulfonate soualene synthetase inhibitor | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-09-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260005313-A1 | ELECTROLYTE INCLUDING ELECTROLYTE SOLVENT, FLUOROETHER, AND BIS(FLUOROSULFONYL) SALT, AND LITHIUM METAL ELECTROCHEMICAL CELLS INCLUDING THE SAME | HCN1, TET1, KCNN1 | ALDH1A1 719/4885HTT 4567/4885DGKA 62/4885 |
| US-12575775-B2 | Intra-body electrode with a poly(3,4-ethylenedioxythiophene)-based coating | BDNF, S100B, L1CAM | ALDH1A1 3379/4885HTT 1282/4885DGKA 3105/4885 |
| US-12638144-B2 | Covalent organic frameworks | ETFB, ETFA, POF1B | ALDH1A1 1570/4885HTT 2406/4885DGKA 991/4885 |
| US-20260100414-A1 | FLAME-RETARDANT OR NON-FLAMMABLE POLYMER GEL ELECTROLYTE, LITHIUM BATTERY INCLUDING THE SAME, SUPRAMOLECULAR POLYMER, AND METHOD OF PREPARING THE SUPRAMOLECULAR POLYMER | FLNA, FLNB, F8 | ALDH1A1 2834/4885HTT 3912/4885DGKA 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.